Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.49 (
reverse transcriptase
)
31,746
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transforming growth factor-beta (TGF-beta) family members regulate a variety of cellular functions and play important roles in cell differentiation.
Activin receptor-like kinase 7
(
ALK7
), a receptor for TGF-beta family members, was initially cloned from rats as an orphan receptor and has been recently shown to be a type I receptor for nodal, activin B and activin AB.
ALK7
is expressed not only in neurons, but also in insulin-producing islet beta cells and white and brown adipose tissues; however, the specific functions of
ALK7
in these tissues are not known. In order to test whether
ALK7
is involved in adipocyte differentiation, we analyzed its expression during adipocyte differentiation.
ALK7
expression was detected in the late phase of adipocyte differentiation by
reverse transcriptase
-polymerase chain reaction (RT-PCR), Western blotting and immunofluorescence staining in 3T3-L1 cells. We also detected the expression of
ALK7
by RT-PCR in stromal vascular fraction (SVF) cells. These results indicated that
ALK7
is a novel marker specifically expressed during the late phase of adipocyte differentiation. Furthermore, our results suggest the possible involvement of nodal or activin B in adipocyte differentiation.
...
PMID:ALK7 is a novel marker for adipocyte differentiation. 1695 60